Fate Therapeutics, Inc. (FATE) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fate Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:03.892 Welcome to the Faith Therapeutics fourth quarter 2023 00:00:03.892 -- 00:00:09.177 financial results conference call. At this time, all participants are in a listen-only 00:00:09.177 -- 00:00:14.301 mode. This call is being webcast live on the investors section of 00:00:14.301 -- 00:00:18.323 Faith's website at faiththerapeutics.com. 00:00:18.965 -- 00:00:22.288 As a reminder, today's call is being recorded. 00:00:22.288 -- 00:00:29.132 I would now like to introduce Scott Washko, president and CEO of Faith Therapeutics. 00:00:29.551 -- 00:00:30.851 Thank you. 00:00:30.851 -- 00:00:35.083 Good afternoon and thanks everyone for joining us for the Faith Therapeutics fourth quarter 00:00:35.083 -- 00:00:36.713 2023 00:00:36.713 -- 00:00:40.394 financial results call. Shortly after 4 p.m. 00:00:40.394 -- 00:00:45.276 Eastern time today, we issued a press release with these results, which can be found 00:00:45.276 -- 00:00:49.197 on the investor section of our website under press releases. 00:00:49.197 -- 00:00:55.858 In addition, our form 10K for the year ended December 31, 2023 was filed shortly thereafter 00:00:57.717 -- 00:01:03.199 and can be found on the Investors section of our website under Financial Information. 00:01:03.320 -- 00:01:07.562 Before we begin, I would like to remind everyone that except for statements of historical 00:01:07.562 -- 00:01:12.925 facts, the statements made by management and responses to questions on this conference 00:01:12.925 -- 00:01:17.988 call are forward-looking statements under the safe harbor provisions of 00:01:17.988 -- 00:01:21.730 the Private Securities Litigation Reform Act of 1995. 00:01:21.730 -- 00:01:23.730 These 00:01:23.811 -- 00:01:28.963 statements involve risks and uncertainties ...